Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,601 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

NCT03674567

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +44 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles JCCC Clinical Research Unit Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 35 locations
View Trial Details
Completed

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

NCT06789224

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +74 more
Locations
  • Kliniken der Stadt Köln gGmbH Cologne, North Rhine-Westphalia, Germany
  • Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Universitätsklinikum Frankfurt Frankfurt, Germany
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz Klinik für Anästhesiologie Mainz, Germany
  • Universitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie Mannheim, Germany
View Trial Details
Completed

Cancer Loyalty Card Study

NCT03994653

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • Imperial College Healthcare NHS Trust London, United Kingdom
View Trial Details
Completed

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

NCT03667716

Conditions
Adnexal Diseases, Advanced Cancer, Breast Cancer, +44 more
Locations
  • University of California Los Angeles (UCLA). Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours

NCT03518606

Conditions
Advanced Solid Tumours, Breast Cancer, Breast Diseases, +25 more
Locations
  • Institut de Cancérologie de l'Ouest - Site Paul Papin Angers, France
  • Centre François Baclesse Caen, France
  • Centre Georges-François Leclerc Dijon, France
  • Institut Paoli-Calmettes Marseille, France
View Trial Details

Related conditions